# Clinical trials recruiting in Alabama: 1,341 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 1,341 trials recruiting or not yet recruiting with a site in Alabama, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Alabama: 1,341 rows for $67.05, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 25 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/alabama

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 1,341
- Recruiting or not yet: 1,341
- Read on: November 19, 2026

## Trials

The 25 newest of 1,341, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07945015 | Neuromodulation of Sleep and Mood: A Multimodal Biomarker Study of Non-Invasive Vagal Nerve Stimulation (MOSAIC-VNS) | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Insomnia, Major Depressive Diorder, miRNAs | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945015) |
| November 18, 2026 | NCT07944508 | A Phase 1 Study of MVB-101 Administered Intraprostatically in Patients With Localized Prostate Cancer Who Are Scheduled for Radical... | MultiValent Biotherapies, Inc. | Phase 1 | Recruiting | Localized Prostate Adenocarcinoma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944508) |
| November 16, 2026 | NCT07939529 | People With Active Viremia Treated With Lenacapavir and Long-Acting Cabotegravir for Effectiveness | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Not yet recruiting | HIV Viremia | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939529) |
| November 10, 2026 | NCT07929506 | Prophylactic CPAP for Late Preterm Infants Born by C-Section to Reduce NICU Admission | Indiana University | Not applicable | Not yet recruiting | Late Preterm Infant | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929506) |
| November 9, 2026 | NCT07926243 | "My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions (MyHP-South) | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Multiple Chronic Conditions, Shared Decision-making | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926243) |
| November 6, 2026 | NCT07923591 | Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923591) |
| November 5, 2026 | NCT07919509 | A Project Assessing the Safety and Feasibility of Using Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Ovarian Cancer During... | University of Alabama at Birmingham | Phase 1 | Not yet recruiting | Cancer, Chemotherapy, Squamous Cell Carcinoma (SCC) | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919509) |
| November 4, 2026 | NCT07916480 | Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis | Arcutis Biotherapeutics, Inc. | Phase 3 | Recruiting | Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema) | 415 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916480) |
| November 4, 2026 | NCT07916259 | The Study of Brave-LC LDN Treatment Trial | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 | Not yet recruiting | Post-acute COVID-19 Syndrome | 1,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916259) |
| November 4, 2026 | NCT07915609 | A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2... | Pfizer | Phase 3 | Recruiting | Obesity, Overweight and/or Obesity, Knee Osteoarthritis, Diabetes Melliuts, Type 2 | 756 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915609) |
| November 4, 2026 | NCT07915479 | Multi-level Intervention to Successfully Transition to Adult Care for Survivors of Childhood and Adolescent Cancers: The BRIDGES-YAS! Study | Georgetown University | Not applicable | Not yet recruiting | Health Care Transition, Survivorship Care, Survivors of Childhood Cancer, Patient Navigation | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915479) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 2, 2026 | NCT07909005 | Long Term Safety Study in Patients With HLH/MAS in Still's Disease Exposed to Gamifant. | Swedish Orphan Biovitrum | Observational | Not yet recruiting | Hemophagocytic Lymphohistiocytosis (HLH), Macrophage Activation Syndrome (MAS), Still Disease | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909005) |
| October 30, 2026 | NCT07907991 | The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Chronic Obstructive Pulmonary Disease | 1,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907991) |
| October 30, 2026 | NCT07906470 | Physiologic Insulin Resensitization (PIR) Treatment in Patients With a Diagnosis of Type 2 Diabetes Mellitus (T2DM) | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Type 2 Diabetes Mellitus | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07906470) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 27, 2026 | NCT07897266 | Non-Invasive Vagus Nerve Stimulation as a Probe to Map Functional Connectivity in Schizophrenia Using Functional Magnetic Resonance Imaging | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Schizophrenia Spectrum Disorders | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897266) |
| October 27, 2026 | NCT07896902 | Xenon MRI to Evaluate Changes to Lung Function Following Bronchoscopic Treatment of Air Trapping in Emphysema | Apreo Health, Inc. | Early phase 1 | Recruiting | Air Trapping, Emphysema, Hyperinflation | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896902) |
| October 27, 2026 | NCT07896317 | Full-Thickness Skin Graft Sizing and Scar Quality | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Graft Healing | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896317) |
| October 26, 2026 | NCT07895654 | Strap To Reduce Apnea in Preterm Infants: A Randomized Crossover Trial | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Apnea of Prematurity, Intermittent Hypoxemia, Bronchopulmonary Dysplasia of Newborn | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895654) |
| October 19, 2026 | NCT07881809 | A Clinical Study of Ixazomib to Reactivate HIV and Reduce HIV Reservoir Size | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | Not yet recruiting | HIV (Human Immunodeficiency Virus) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881809) |
| October 19, 2026 | NCT07881757 | A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight... | Pfizer | Phase 3 | Recruiting | Apnea, Sleep Disorders, Overweight and/or Obesity | 258 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881757) |
| October 13, 2026 | NCT07871513 | A Study to Assess the Safety and Efficacy of Co-Reconstituted TrenibotulinumtoxinE and OnabotulinumtoxinA in Adult Participants With... | AbbVie | Phase 2 | Recruiting | Upper Facial Lines, Glabellar Lines | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871513) |
| October 9, 2026 | NCT07869147 | Study of ORJ-001 for the Treatment of IPF | Oorja Bio, Inc. | Phase 2 | Recruiting | Idiopathic Pulmonary Fibrosis | 95 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869147) |
| October 9, 2026 | NCT07868419 | Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets | Trevi Therapeutics | Phase 3 | Recruiting | Idiopathic Pulmonary Fibrosis | 201 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868419) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| University of Alabama at Birmingham | Birmingham | 345 |
| University of Alabama at Birmingham Cancer Center | Birmingham | 61 |
| University of Alabama | Birmingham | 41 |
| Children's Hospital of Alabama | Birmingham | 39 |
| The University of Alabama at Birmingham | Birmingham | 29 |
| University of Alabama Birmingham | Birmingham | 28 |
| USA Health Strada Patient Care Center | Mobile | 19 |
| Children's of Alabama | Birmingham | 15 |
| Clearview Cancer Institute | Huntsville | 13 |
| Mobile Infirmary Medical Center | Mobile | 13 |
| University of Alabama Hospital | Birmingham | 11 |
| Birmingham VA Medical Center, Birmingham, AL | Birmingham | 10 |
| Thomas Hospital | Fairhope | 10 |
| University of Alabama - Birmingham | Birmingham | 10 |
| Auburn University | Auburn | 9 |
| University of South Alabama Mitchell Cancer Institute | Mobile | 9 |
| University of South Alabama | Mobile | 8 |
| Cullman Clinical Trials | Cullman | 8 |
| Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis | Daphne | 8 |
| Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland | Saraland | 8 |
| Alabama Oncology | Birmingham | 7 |
| Huntsville Hospital | Huntsville | 7 |
| Urology Centers of Alabama | Homewood | 7 |
| Infirmary Cancer Care | Mobile | 7 |
| Cahaba Dermatology & Skin Health Center | Birmingham | 7 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 15 |
| Phase 1 | 77 |
| Phase 1/2 | 66 |
| Phase 2 | 248 |
| Phase 2/3 | 38 |
| Phase 3 | 374 |
| Phase 4 | 43 |
| Not applicable | 312 |
| Observational | 168 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Obesity | 46 |
| Neoplasms | 44 |
| Carcinoma, Non-Small-Cell Lung | 40 |
| Breast Neoplasms | 35 |
| Overweight | 34 |
| Diabetes Mellitus, Type 2 | 28 |
| Ovarian Neoplasms | 26 |
| Leukemia, Myeloid, Acute | 25 |
| Cardiovascular Diseases | 24 |
| Pulmonary Disease, Chronic Obstructive | 23 |
| Multiple Myeloma | 22 |
| Heart Failure | 21 |
| Endometrial Neoplasms | 21 |
| Hypertension | 20 |
| Anemia, Sickle Cell | 17 |
| Depressive Disorder, Major | 17 |
| Lung Neoplasms | 17 |
| Colorectal Neoplasms | 17 |
| Cystic Fibrosis | 16 |
| Neoplasm Metastasis | 16 |
| Parkinson Disease | 15 |
| Depression | 14 |
| Hematologic Neoplasms | 14 |
| Pancreatic Neoplasms | 14 |
| Lung Diseases | 14 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Alabama at Birmingham | 242 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 39 |
| National Cancer Institute (NCI) | 33 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 33 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 26 |
| Children's Oncology Group | 26 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 22 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 18 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 16 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 15 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 14 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 14 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 14 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 13 |
| Auburn University | 13 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 12 |
| VA Office of Research and Development | 12 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 11 |
| NRG Oncology | 11 |
| SWOG Cancer Research Network | 10 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 10 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 10 |
| Duke University | 10 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 10 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 9 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Alabama

- [Hospitals in Alabama, United States](https://specstream.ai/data/businesses/hospitals/alabama-united-states)
- [Outpatient care facilities in Alabama, United States](https://specstream.ai/data/businesses/outpatient-care-facilities/alabama-united-states)
- [Sports medicine clinics in Alabama, United States](https://specstream.ai/data/businesses/sports-medicine-clinics/alabama-united-states)
- [B2B marketing consultants in Alabama, United States](https://specstream.ai/data/businesses/b2b-marketing-consultants/alabama-united-states)
- [Divorce and family law firms in Alabama, United States](https://specstream.ai/data/businesses/divorce-and-family-law-firms/alabama-united-states)
- [Insulation contractors in Alabama, United States](https://specstream.ai/data/businesses/insulation-contractors/alabama-united-states)
